|Bid||37.11 x 150000|
|Ask||37.28 x 150000|
|Day's range||36.22 - 37.32|
|52-week range||17.58 - 42.95|
|Beta (5Y monthly)||0.46|
|PE ratio (TTM)||N/A|
|Forward dividend & yield||0.30 (0.81%)|
|Ex-dividend date||21 Apr 2021|
|1y target est||N/A|
GETINGE AB (GNGBY) made it through our "Recent Price Strength" screen and could be a great choice for investors looking to make a profit from stocks that are currently on the move.
If you are looking for stocks that are well positioned to maintain their recent uptrend, GETINGE AB (GNGBY) could be a great choice. It is one of the several stocks that passed through our "Recent Price Strength" screen.
Swedish medical equipment maker Getinge is building a second production line for sterile transfer products to meet a spike in demand as COVID-19 vaccine manufacturing takes off. The maker of products for surgery, intensive care and sterilization saw a spike in demand in 2020 for ventilators and other advanced life support equipment due to the pandemic, delivering no less than 26,000 ventilators. While demand for ventilators peaked earlier in the year, it remained strong in the fourth quarter for extracorporeal membrane oxygenation (ECMO) machines, a kind of artificial lung, the company said on Thursday.